@article{article, title  = {{An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International}},

 publisher = {{Oxford University Press (OUP)}},

 url = {{}},

 year = {{2021}},

 month = {{11}},

 author = {{Müller R-U and Messchendorp AL and Birn H and Capasso G and Cornec-Le Gall E and Devuyst O and van Eerde A and Guirchoun P and Harris T and Hoorn EJ and Knoers NVAM et al}},

 doi = {{10.1093/ndt/gfab312}},

 journal = {{Nephrology Dialysis Transplantation}},

 note = {{Accessed on 2024/12/22}}}